CHO cell culture media

Thermo Fisher Scientific (Waltham MA; NYSE: TMO; ~$43B revenue 2024) is the world's largest manufacturer of cell culture media through its Gibco brand — the dominant label in CHO (Chinese Hamster Ovary) cell culture media for biopharmaceutical manufacturing. Gibco CHO-S Serum-Free Medium, GlutaMAX supplement, CD CHO medium, and EX-CELL Advanced CHO media series supply the majority of global monoclonal antibody manufacturing processes. Thermo Fisher's cell culture media is manufactured primarily at its Grand Island, NY facility (acquired from Life Technologies, itself formerly GIBCO BRL), which is the single most important cell culture media manufacturing site in North America. Thermo Fisher also operates a major media production site in Paisley, Scotland (UK) that serves European biopharmaceutical manufacturing. Gibco media formulations are validated into more FDA-approved biologics manufacturing processes than any other supplier — creating regulatory lock-in equivalent to Cytiva's position in chromatography resins. The 2014 Thermo Fisher merger with Life Technologies (which itself had acquired Invitrogen in 2008 and GIBCO BRL in 2000) consolidated what were once multiple competing cell culture brands into a single dominant supplier.

Merck KGaA (Darmstadt; family-owned since 1668; Life Science division ~$9B revenue) produces CHO cell culture media through its MilliporeSigma brand in North America and SAFC (Sigma-Aldrich Formulation & Custom manufacturing) globally. SAFC Biosciences is the custom media manufacturing arm that produces proprietary 'black box' formulations for major biopharmaceutical companies under NDA — meaning a significant fraction of industry media demand is manufactured exclusively by Merck KGaA under confidential contracts. Merck KGaA's media manufacturing sites include St. Louis, Missouri (Sigma-Aldrich legacy site) and Martillac, France (custom bioscience manufacturing). The same Merck KGaA Darmstadt organization manufactures EUV photoresists (display and semiconductor), liquid crystals for flat panels, and Fractogel chromatography resins — a German family-controlled conglomerate touching monoclonal antibody media, display materials, and semiconductor chemicals from one Hessen campus.

Life sciences tools company (Marlborough, MA; wholly-owned by Danaher Corporation since $21.4B acquisition of GE Healthcare Life Sciences in 2020) that manufactures Whatman membrane filter papers and sterile filtration products alongside its dominant chromatography resin (Capto, Sephadex, Sepharose series) and bioreactor (WAVE, XDR) platforms. Cytiva is the successor to GE Healthcare Life Sciences and Amersham Biosciences. Whatman-branded products include nitrocellulose and mixed cellulose ester membranes used in sterile filtration, diagnostics, and laboratory applications. Cytiva's role in sterile filtration is secondary to Merck KGaA and Pall — Whatman filters are more prevalent in laboratory/QC applications than primary pharmaceutical manufacturing sterilization — but Cytiva's ownership alongside Pall within Danaher creates the world's most concentrated supply position in biopharmaceutical manufacturing consumables. Danaher's combined Pall + Cytiva platform spans filtration, chromatography, bioreactors, and cell culture media — covering essentially every critical consumable step in a biologics manufacturing process.

Fujifilm Irvine Scientific (Santa Ana CA; subsidiary of FUJIFILM Corporation Tokyo) is a specialty cell culture media manufacturer focused on serum-free and chemically-defined CHO media. Its IS CHO-CD series (IS CHO-CD, IS CHO-CD EfficientFeed, IS CHO-CD XP) are high-performance CHO media used in commercial mAb manufacturing at major biopharmaceutical companies. Fujifilm Irvine Scientific also manufactures media for ART (assisted reproductive technology — IVF media), cell therapy, and vaccine production. The company is a wholly owned subsidiary of FUJIFILM Corporation — the Japanese film and imaging company that pivoted into life sciences and healthcare after digital photography destroyed its core business in the early 2000s. The same FUJIFILM brand that manufactured photographic film now supplies the cell culture media used to manufacture Humira and Herceptin. FUJIFILM's life sciences expansion also includes biopharmaceutical contract manufacturing (FUJIFILM Diosynth Biotechnologies), making it a vertically integrated biopharmaceutical supplier.

German laboratory and bioprocessing equipment company (Göttingen; XETRA: SRT; ~€3.4B revenue) that manufactures Sartopore 2 (PES — polyethersulfone) and Sartopore Platinum (modified PES) sterilizing membranes — the primary European alternative to Merck/Pall membrane platforms. Sartorius holds an estimated ~15% share of the pharmaceutical sterilizing filtration market, with particular strength in European biologics manufacturing. Sartorius also makes Sartocon cassette systems for tangential flow filtration (TFF), Stedim biocontainers (single-use bags), and Biowave bioreactor systems — making it, like Danaher, a vertically integrated supplier across multiple critical biopharmaceutical manufacturing unit operations. Sartorius acquired Stedim (France) in 2007 and has organically grown its bioprocessing portfolio. Göttingen primary manufacturing; additional production in Yauco, Puerto Rico (acquired via Sartorius Stedim Biotech).